Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...

Calgary, Alberta, September 4, 2025 –TheNewswire -Universal Ibogaine Inc. (IBO:CA) (TSXV: IBO, in USA: IBOGF, in Germany FSE:JC4) (“UI” or the “Company) is pleased to announce its intention to file, ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

Entero Therapeutics to integrate applications in planned Phase 3 study of latiglutenase for celiac disease and explore additional uses of technology in clinical trial compliance BOCA RATON, Fla., Sept ...

Enrollment in the SAFEGUARD trial is ongoing at multiple centers globallyCompany on-track to share Phase 2b data in 2H 2027MIAMI, Dec. 18, 2025 ...

Made possible through pilot funding and informed by user experience research, Mayo Clinic's Clinical Trials Beyond Walls initiative leverages telehealth, remote assessments and other hospital-at-home ...

This milestone opens a path for FibroScan ® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

Iterum Therapeutics plc announced the publication of results from its Phase 3 clinical trial, REASSURE, in NEJM Evidence, which evaluated the efficacy of oral sulopenem compared to Augmentin® in ...